Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

VENABLE EXPANDS ITS PATENT PROSECUTION CAPABILITIES IN ITS SAN FRANCISCO OFFICE WITH THE ADDITION OF BENJAMIN PELLETIER

VENABLE EXPANDS ITS PATENT PROSECUTION CAPABILITIES IN ITS SAN FRANCISCO OFFICE WITH THE ADDITION OF BENJAMIN PELLETIER

Venable LLP is pleased to announce that Benjamin C. Pelletier has joined the firm’s growing Patent Prosecution and Counseling Practice as counsel in the San Francisco office. Mr. Pelletier’s practice focuses on clients in the biotechnology, pharmaceutical, life science, and medical device industries.

Mr. Pelletier advises clients in building and protecting patent assets throughout the world, and provides strategic counseling with respect to intellectual property due diligence, freedom-to-operate issues, analysis of third-party patents, and supporting non-infringement and invalidity opinions. He holds an advanced degree in bioengineering, and spent many years working at a leading biotechnology company as an engineer and project manager before attending law school. His experience broadly spans the areas of monoclonal antibodies and antibody-drug conjugates (ADCs), stem cells, tissue engineering, 3D bioprinting, biosensors, genomic sequencing, and bioinformatics, as well as companion diagnostic assay systems and devices.

Justin E. Pierce, chair of Venable’s Intellectual Property Division, said, “Ben’s addition is a key part of our strategy to expand and broaden Venable’s presence in the intellectual property sector to meet the growing needs of our client base, especially when it comes to patent prosecution in the biosciences arena.”

James E. Nelson, partner-in-charge of the firm’s San Francisco office, said, “His expertise and relationships will allow us to further expand our capacity to engage and support clients in pharma and biotech. Further, with Ben’s addition, our San Francisco office continues its smart growth to more than 30 attorneys focused on building client relationships and leveraging skills covering a wide swath of client needs.”

“Ben joins a team with a deep bench of former patent examiners, strategists, and litigators with industry experience and advanced technical degrees who are skilled at advising clients on maximizing the value of their intellectual property portfolios,” said Dr. Michael A. Sartori, chair of Venable’s Patent Prosecution and Counseling Practice. “Our team has prepared and prosecuted tens of thousands of patents worldwide for U.S. and international clients, and we look forward to Ben’s contributions to our team as we continue to grow our top-ranked patent practice.”

Commenting on his move to Venable, Mr. Pelletier said, “My clients, who typically operate at the intersections of biology, medicine, engineering, and data science, are increasingly looking for law firms that provide a comprehensive suite of legal services to them; including patent prosecution. For example, Venable’s broad experience implementing successful regulatory and food and drug law strategies perfectly complements the patent prosecution and counseling work I do for my clients.”

Mr. Pelletier holds a J.D. from the University of California, Hastings College of the Law, an M. Eng. in bioengineering from the University of California, San Diego, and B.S. in bioengineering from the University of California, Berkeley.

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post